In 2018, the British government officially allowed the prescription of cannabis-based medicinal products. This legal change came in response to repeated requests from patients and their families for access to effective treatments. But has this provision been as effective as expected?
Step by Step Towards Private Prescriptions
Although the NHS prescribes cannabis-based medicinal products for a number of specific conditions such as rare and severe epilepsy and muscle spasm issues related to multiple sclerosis, statistics show that a significant portion of prescriptions are made through private providers. This has become a contentious issue, especially in situations where patients are seeking quicker and more effective treatments.
Many patients with serious issues turn to private centers to benefit from better services. While this trend seems to have made access to modern treatments easier, it has also brought a lot of criticism. Are these private prescriptions truly beneficial for patients, or are they only advantageous for private companies?
Patient Experiences: Hope or Despair?
Patient experiences indicate that some have witnessed significant improvements after receiving prescriptions from private centers. However, others complain about the high costs of treatment and lack of insurance coverage. In fact, this has become a serious challenge. Do all individuals have the financial means to utilize private services?
These questions arise while many patients are still seeking effective solutions to manage their pain and suffering. In this context, paying attention to the real experiences of patients can help illuminate the hidden aspects of this issue.
Source: theguardian.com
